Zoom Logo

RADx Webinar Series - Shared screen with speaker view
Liwei Qi
58:46
can you explain more about using alternative transport media or lysis buffer?
Anupam
59:17
will this PPT be available?
Tania Fernandez
01:00:07
can you please explain use of alternate saliva collection devices? Also could you talk about the importance of pre-EUA submissions
cgaydos1
01:07:54
Ah so cute
Liwei Qi
01:09:08
for the saliva sample type, is buccal swab acceptable?
Liwei Qi
01:13:47
is there a higher throughput demand at the POCT site?
Liwei Qi
01:14:17
current POCT device only test 1 sample at a time.
Richard Creager
01:16:21
Has the FDA reconsidered the use of TCID50 for LOD determination of antigen tests. There is considerable difference among different TCID50 preps (manufacturer to manufacturer and lot to lot)?
cgaydos1
01:16:58
Oral or throat swabs can be considered also as a sample type
cgaydos1
01:18:03
Excellent presentation Erika
Liwei Qi
01:18:20
the current LOD determination method is confusing and not accurate. different companies use different measure units. is there a concern to it?
cgaydos1
01:23:22
Symptoms are what the person reports, therefor at the discretion of the person to report. (signs are what a clinician sees like a discharge or lesion or fever and reports.)
Lea Widdice
01:24:56
Just information for those on the Webinar: As a doctor seeing patients in a busy primary care clinic, I am having more and more patients refusing COVID testing because they don't want to have an NP swab. This is happening especially among patients who have already had an NP sample taken for COVID testing.
cgaydos1
01:26:37
Agree. This is why it will be important to validate alternative sample types like mid turbinate or nasal swab.
Lea Widdice
01:28:52
Excellent presentation! Thank you!
* Rtndo
01:29:01
Thank you
cgaydos1
01:29:13
Fantastic presentation!
oche agbaji
01:29:18
Great Presentation.